Guidelines Establish Minimum Negative Margins in DCIS
Three medical organizations including ASCO have issued a guideline on margins in breast conserving surgery for patients with ductal carcinoma in situ. (Source: CancerNetwork)
Source: CancerNetwork - August 18, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Breast Cancer News Source Type: news
New Guidelines Set Safe Surgery Margins for Some Breast Cancers
FRIDAY, Aug. 12, 2016 -- New surgery guidelines for certain breast cancer patients could reduce both unnecessary surgeries and recurrence rates, three U.S. cancer groups say.
The guideline is for treatment of women with ductal carcinoma in situ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 15, 2016 Category: Journals (General) Source Type: news
New DCIS consensus guideline could curb unnecessary breast surgery and reduce health system costs
(American Society for Radiation Oncology) Three leading national cancer organizations today issued a consensus guideline for physicians treating women who have ductal carcinoma in situ (DCIS) treated with breast-conserving surgery with whole breast irradiation. The new guideline has the potential to save many women from unnecessary surgeries while reducing costs to the health care system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 15, 2016 Category: Cancer & Oncology Source Type: news
Needle biopsy hormone testing unnecessary for DCIS
Patients with ductal carcinoma in situ (DCIS) breast cancer don't need hormone...Read more on AuntMinnie.comRelated Reading:
Delayed rad therapy puts women with DCIS at risk
ASBrS: No, we're not overtreating DCIS
Rates of high-grade DCIS increase with age
Various DCIS treatments produce similar survival rates
Kopans: JAMA Oncology paper misinterprets DCIS data (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2016 Category: Radiology Source Type: news
Are provider-related factors affecting the likelihood of breast preservation?
( < i > The JAMA Network Journals < /i > ) Do regional practice patterns for radiotherapy for ductal carcinoma in situ (DCIS) breast cancer increase the likelihood of mastectomy when there is a second breast cancer in women who did not receive radiotherapy at the initial DCIS diagnosis? (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2016 Category: Cancer & Oncology Source Type: news
Medical News Today: Aggressive breast cancer identified with new technique
A combination of math and imaging can distinguish aggressive forms of ductal carcinoma in situ - or stage 0 breast cancer - from non-aggressive forms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2016 Category: Consumer Health News Tags: Breast Cancer Source Type: news
New technology helps ID aggressive early breast cancer
Researchers have developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2016 Category: Science Source Type: news
New technology helps ID aggressive early breast cancer
(University of Michigan Health System) Researchers at the University of Michigan developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2016 Category: Global & Universal Source Type: news
Testing After DCIS Needle Biopsies: $35 Million BoondoggleTesting After DCIS Needle Biopsies: $35 Million Boondoggle
Testing core needle biopsy specimens of ductal carcinoma in situ (DCIS) for hormone receptors is wasteful because testing is better done after surgery. Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 24, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news
Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People for 2016
Contact: Samiha KhannaPhone: 919-419-5069Email: samiha.khanna@duke.eduhttps://www.dukehealth.org
FOR IMMEDIATE RELEASE on Thursday, April 21, 2016
DURHAM, N.C. -- Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute, has been named one of TIME’s 100 most influential people for 2016 as a pioneer in her field.
One of the world’s foremost experts in early-stage breast cancers, Hwang has become an international leader calling for research to guide treatment for ductal carcinoma in situ (DCIS), in which abnormal cells are detected in the lining of a milk duct, but haven’t spread to other tissues.
DCIS...
Source: DukeHealth.org: Duke Health Features - April 22, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news
Delayed rad therapy puts women with DCIS at risk
Women being treated for ductal carcinoma in situ (DCIS) are at higher risk...Read more on AuntMinnie.comRelated Reading:
Socioeconomic factors affect patient care in radiology
Racial discrepancies persist in breast cancer diagnoses
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients
ASTRO publishes guidelines for accelerated whole-breast RT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 18, 2016 Category: Radiology Source Type: news
Early stage breast cancer does need treatment, study finds
Kathleen Doheny, HealthDay News Early stage breast cancers known as DCIS, ductal carcinoma in situ, should be treated with surgery, not a "wait-and-watch" approach, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 15, 2016 Category: Consumer Health News Source Type: news
Early Stage Breast Cancer Does Need Treatment, Study Finds
FRIDAY, April 15, 2016 -- Early stage breast cancers known as DCIS (ductal carcinoma in situ) should be treated with surgery, not a "wait-and-watch" approach, according to new research.
Experts have debated whether to treat early DCIS or simply... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2016 Category: Journals (General) Source Type: news
ASBrS: No, we're not overtreating DCIS
More than 50% of women diagnosed with ductal carcinoma in situ (DCIS) that...Read more on AuntMinnie.comRelated Reading:
5 ways imaging can reduce breast cancer overdiagnosis
Could a pill improve breast cancer diagnosis?
New study to tackle personalized breast screening
Mammo false-positive rate highest in younger women
Rates of high-grade DCIS increase with age (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 15, 2016 Category: Radiology Source Type: news
ACR and SBI Continue to Recommend Regular Mammography Starting at Age 40
Washington, DC (Oct. 20, 2015) — As our shared goal is to save the most lives possible from breast cancer, the American College of Radiology (ACR) and Society of Breast Imaging (SBI) continue to recommend that women get yearly mammograms starting at age 40. New American Cancer Society (ACS) breast cancer screening guidelines, and previous data used by the United States Preventive Services Task Force (USPSTF) to create their recommendations, state that starting annual mammography at age 40 saves the most lives.
“The ACS has strongly reaffirmed that mammography screening saves lives. The new ACS guidelines show ...
Source: American College of Radiology - April 13, 2016 Category: Radiology Source Type: news
